Federal Register / Vol. 62, No. 241 / Tuesday, December 16, 1997 / Notices 65815

a forum for the discussion and

evaluation of the research findings in

the selected area. At each symposia the

participants consider the quality and

reproducibility of the research findings

for evaluating the degree to which

scientific evidence can support a causal

linkage between EMF and biological/

health effects. Written reports

summarizing the deliberations of

breakout group discussion sessions are

publicly available for the first

symposium (send name and address to

f:919–541–0144 or from EMFRAPID

Progrm/LCBRA, NIEHS, PO Box 12233,

MD EC–16, Research Triangle Park, NC

27709). The participants for each

symposium include scientists studying

EMF effects in the science area being

reviewed, experts on measuring and

producing EMF exposures, risk

assessment experts, and recognized

scientists in the area being evaluated

who may have little EMF experience but

can contribute to a broader

understanding of the research findings.

Following the symposia a working

group meeting is planned for June 1998.

The working group will use information

from the symposia’s discussions as well

as perform on overall critical evaluation

of the literature and produce a report.

This document will draw conclusions

on the strength and robustness of the

data and its implications for human

health effects and disease etiology.

Per the request from Congress, the

NIEHS will use the final report of the

working group, information obtained

from the science review symposia and

other relevant information to prepare a

report to Congress on the potential for

human health effects from exposure to

EMF that result from the production and

distribution of electricity. This report

will be made publicly available at the

time it is sent to Congress. Detailed

information about the EMFRAPID

Program is available at the time it is sent

to Congress. Detailed information about

the EMFRAPID Program is available on

the world wide web at

www.niehs.nih.gov/emfrapid/

home.htm.

Science Review Symposium on

Epidemiology: Open to the Public

In its series of science review

symposia, the second EMF Science

Review Symposium is scheduled for

January 12–14, 1998 at the Camberley

Gunter Hotel, San Antonio, Texas. This

meeting includes plenary overview talks

on exposure assessment, methodological

issues and problems in epidemiological

studies as well as substantive talks on

disease endpoints. Breakout group

sessions are planned for in-depth

discussions of the research findings

from epidemiological studies as well as

methodological and exposure

assessment issues. This meeting is open

to the public and the registration fee is

$85; for registration information contact

t:919–541–7534 or f:919–541–0144.

Science Review Symposium on Clinical

and In vivo Research Studies

Planning is underway for the third

EMF Science Review Symposium, April

6–9, 1998 at the Hyatt Regency at Civic

Plaza, Phoenix, Arizona. To receive

additional information about this

meeting, send your name and address to

f:919–541–0144 or EMFRAPID Program/

LCBRA, NIEHS, PO Box 12233, MD EC–

16, Research Triange Park, NC 27709.

Dated: December 2, 1997.

Samuel H. Wilson,

Deputy Director, National Institute of

Environmental Health Sciences.

[FR Doc. 97–32742 Filed 12–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Meeting:

AIDS Research Advisory Committee,

NIAID

Pursuant to Public Law 92–463,

notice is hereby given of the meeting of

the AIDS Research Advisory Committee,

National Institute of Allergy and

Infectious Diseases, on January 28, 1998

in Conference Room 1A1 in the Solar

Building located at 6003 Executive

Blvd, Rockville, Maryland.

The entire meeting will be open to the

public from 8:30 a.m. until

adjournment. The AIDS Research

Advisory Committee (ARAC) advises

and makes recommendations to the

Director, National Institute of Allergy

and Infectious Diseases, on all aspects of

research on HIV and AIDS related to the

mission of the Division of AIDS

(DAIDS).

The Committee will provide advice

on scientific priorities, policy, and

program balance at the Division level.

The Committee will review the progress

and productivity of ongoing efforts, and

identify critical gaps/obstacles to

progress. Attendance by the public will

be limited to space available.

Ms. Rona L. Siskind, Executive

Secretary , AIDS Research Advisory

Committee, DAIDS, NIAID, NIH, Solar

Building, Room 2A21, telephone 301–

435–3732, will provide a summary of

the meeting and a roster of committee

members upon request. Individuals who

plan to attend and need special

assistance, such as sign language

interpretation or other reasonable

accommodations, should contact Ms.

Siskind in advance of the meeting.

(Catalog of Federal Domestic Assistance

Program Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health).

Dated: December 10, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–32743 Filed 12–15–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute of Allergy and

Infectious Diseases Special Emphasis

Panel (SEP) meeting:

Name of SEP: Amended Unsolicited R01

(Telephone Conference Call).

Date: January 6, 1998.

Time: 1:00 p.m. to Adjournment.

Place: Teleconference, 6003 Executive

Blvd., Solar Building, Room 4C01, Bethesda,

MD 20892, (301) 496–2500.

Contact Person: Dr. Dianne E. Tingley,

Scientific Review Adm., 6003 Executive

Boulevard, Solar Bldg., Room 4C07,

Bethesda, MD 20892, (301) 496–2550.

Purpose/Agenda: To evaluate a grant

application.

The meeting will be closed in accordance

with the provision set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Application and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.855, Immunology, Allergic

and Immunologic Diseases Research; 93.856,

Microbiology and Infectious Diseases

Research, National Institutes of Health.)

Dated: December 10, 1997.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–32744 Filed 12–15–97; 8:45 am]

BILLING CODE 4140–01–M